Pharmacokinetics of moxifloxacin, a novel 8-methoxy-quinolone, in patients with renal dysfunction
about
Prediction of Pharmacokinetics and Penetration of Moxifloxacin in Human with Intra-Abdominal Infection Based on Extrapolated PBPK ModelMoxifloxacin Induced Seizures -A Case Report.Moxifloxacin (Avelox): a novel fluoroquinolone with a broad spectrum of activity.Moxifloxacin in the treatment of skin and skin structure infections.Moxifloxacin in respiratory tract infections.The influence of continuous venovenous haemodialysis on the pharmacokinetics of multiple oral moxifloxacin administration to patients with severe renal dysfunction.Penetration of moxifloxacin into bone evaluated by Monte Carlo simulation.10 years' experience with the pneumococcal quinolone moxifloxacin.Pharmacokinetics of consecutive oral moxifloxacin (400 mg/day) in patients with respiratory tract infection.Population pharmacokinetics and target attainment analysis of moxifloxacin in patients with diabetic foot infections.Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.Moxifloxacin does not alter ciclosporin pharmacokinetics in transplant patients: a multiple-dose, uncontrolled, single-centre study.Bactericidal activity of moxifloxacin on exponential and stationary phase cultures of Mycobacterium tuberculosis.Lack of ethnic differences of moxifloxacin and metabolite pharmacokinetics in East Asian men.Moxifloxacin: a respiratory fluoroquinolone
P2860
Q35127513-810A258A-5A93-4782-A181-02BE8D9FE175Q35846371-BBFA6022-BB1A-4DCD-A631-49CFCD0CACC3Q35917226-92A4DFB9-5196-436D-A10C-10BD9A15183BQ35919259-D9B81FFD-34A0-4811-A497-D8C2D80E5276Q36066098-9DE892F8-E5CA-4E01-B50A-31752E7F48F9Q36379846-FB1954DB-4EAA-4FD0-B1CA-C7894D483B2EQ37190660-72E51A10-E66D-4ABD-A6FE-FAE3B4FBF723Q37579919-ACA5CD45-BF8B-4880-AA40-5DDE521FF531Q40873764-E6C17015-753F-4377-A7BD-A417BDAA6CD7Q41534755-56CFCC99-976E-47D3-858E-966FFEE24068Q41994529-7AE23735-1A9A-4BEA-A91B-ADE3460CC1E5Q43103062-BC4A2EFC-6FC9-4DD7-9B44-FB6700F217BAQ46021301-DCE4AF2E-9E14-401D-BB0E-DAE1F5DD6840Q47420752-DB749535-3D9F-4BD6-9F66-3EF8DD05A7BAQ57778170-5BB57C1B-BBC9-4213-A6B4-0A919A3C8549
P2860
Pharmacokinetics of moxifloxacin, a novel 8-methoxy-quinolone, in patients with renal dysfunction
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Pharmacokinetics of moxifloxac ...... atients with renal dysfunction
@ast
Pharmacokinetics of moxifloxac ...... atients with renal dysfunction
@en
type
label
Pharmacokinetics of moxifloxac ...... atients with renal dysfunction
@ast
Pharmacokinetics of moxifloxac ...... atients with renal dysfunction
@en
prefLabel
Pharmacokinetics of moxifloxac ...... atients with renal dysfunction
@ast
Pharmacokinetics of moxifloxac ...... atients with renal dysfunction
@en
P2093
P2860
P1476
Pharmacokinetics of moxifloxac ...... atients with renal dysfunction
@en
P2093
P2860
P304
P356
10.1046/J.0306-5251.2001.01557.X
P407
P577
2002-03-01T00:00:00Z